BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 35050167)

  • 21. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NOD-like receptors in intestinal homeostasis and epithelial tissue repair.
    Parlato M; Yeretssian G
    Int J Mol Sci; 2014 May; 15(6):9594-627. PubMed ID: 24886810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maintenance of gut homeostasis by the mucosal immune system.
    Okumura R; Takeda K
    Proc Jpn Acad Ser B Phys Biol Sci; 2016; 92(9):423-435. PubMed ID: 27840390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial Signaling at the Intestinal Epithelial Interface in Inflammation and Cancer.
    Coleman OI; Haller D
    Front Immunol; 2017; 8():1927. PubMed ID: 29354132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential crosstalk between epithelial cells, dendritic cells and bacteria in a co-culture model.
    Zoumpopoulou G; Tsakalidou E; Dewulf J; Pot B; Grangette C
    Int J Food Microbiol; 2009 Apr; 131(1):40-51. PubMed ID: 19264370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Regulation of Intestinal Inflammation and Cancer Development by Type 2 Immune Responses.
    Gamez-Belmonte R; Erkert L; Wirtz S; Becker C
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbiota and Colorectal Cancer: From Gut to Bedside.
    Silva M; Brunner V; Tschurtschenthaler M
    Front Pharmacol; 2021; 12():760280. PubMed ID: 34658896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut Microbial Metabolite-Mediated Regulation of the Intestinal Barrier in the Pathogenesis of Inflammatory Bowel Disease.
    Iyer N; Corr SC
    Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SCFA: mechanisms and functional importance in the gut.
    Martin-Gallausiaux C; Marinelli L; Blottière HM; Larraufie P; Lapaque N
    Proc Nutr Soc; 2021 Feb; 80(1):37-49. PubMed ID: 32238208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut microbiota-derived metabolites as key mucosal barrier modulators in obesity.
    Wei YX; Zheng KY; Wang YG
    World J Gastroenterol; 2021 Sep; 27(33):5555-5565. PubMed ID: 34588751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucosal innate immune cells regulate both gut homeostasis and intestinal inflammation.
    Kurashima Y; Goto Y; Kiyono H
    Eur J Immunol; 2013 Dec; 43(12):3108-15. PubMed ID: 24414823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms by Which the Gut Microbiota Influences Cytokine Production and Modulates Host Inflammatory Responses.
    Mendes V; Galvão I; Vieira AT
    J Interferon Cytokine Res; 2019 Jul; 39(7):393-409. PubMed ID: 31013453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic Regulation of Group 3 Innate Lymphoid Cells and Their Role in Inflammatory Bowel Disease.
    Song D; Lai L; Ran Z
    Front Immunol; 2020; 11():580467. PubMed ID: 33193381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut Microbiota Modulation on Intestinal Mucosal Adaptive Immunity.
    Wang L; Zhu L; Qin S
    J Immunol Res; 2019; 2019():4735040. PubMed ID: 31687412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbial Tryptophan Metabolism Tunes Host Immunity, Metabolism, and Extraintestinal Disorders.
    Liu M; Nieuwdorp M; de Vos WM; Rampanelli E
    Metabolites; 2022 Sep; 12(9):. PubMed ID: 36144238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Integrated Outlook on the Metagenome and Metabolome of Intestinal Diseases.
    Aw W; Fukuda S
    Diseases; 2015 Nov; 3(4):341-359. PubMed ID: 28943629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-protein diets for weight management: Interactions with the intestinal microbiota and consequences for gut health. A position paper by the my new gut study group.
    Blachier F; Beaumont M; Portune KJ; Steuer N; Lan A; Audebert M; Khodorova N; Andriamihaja M; Airinei G; Benamouzig R; Davila AM; Armand L; Rampelli S; Brigidi P; Tomé D; Claus SP; Sanz Y
    Clin Nutr; 2019 Jun; 38(3):1012-1022. PubMed ID: 30274898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer.
    Jackson DN; Theiss AL
    Gut Microbes; 2020 May; 11(3):285-304. PubMed ID: 30913966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.